Crossmark

Systematic investigation of the potential multi-target pharmacological mechanisms of Astragaloside IV in polycystic ovary syndrome via network pharmacology and in vivo/in vitro experiments

Crossref DOI link: https://doi.org/10.1007/s00210-025-04667-x

Published Online: 2025-10-09

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Feng, Ying

Wu, Lei

Liu, Jianrong
Funding

Funding for this research was provided by:

Shanxi Key Laboratory of Integrated Traditional Chinese and Western Medicine in Reproductive Medicine (zyyyjs2024017)

the Shanxi Traditional Chinese Medicine Innovation Project: Formulation Development of Shuqiong Zhuyun Decoction for the Treatment of PCOS-related Infertility (2025kjzy011)

the Central Government Guiding Local Science and Technology Development Fund Project (YDZJSX2022A069)
License Information

Text and Data Mining valid from 2025-10-09

Version of Record valid from 2025-10-09
More Information

Article History

Received: 14 August 2025

Accepted: 16 September 2025

First Online: 9 October 2025

Declarations

:

: This study was approved by the Medical Ethics Committee of the Shanxi Provincial People's Hospital. The ethics approval number is 852 from the Provincial Medical Department.

: Informed consent was obtained from all the participants included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below